Grabar Law investigates shareholder claims against Aardvark, Coastal Financial, Erasca, and New Era Energy for alleged misconduct.

Grabar Law Office is investigating shareholder claims against four companies—Aardvark Therapeutics, Coastal Financial Corporation, Erasca, Inc., and New Era Energy & Digital—for alleged securities violations and breaches of fiduciary duties. The claims involve misleading statements about drug safety, credit quality, clinical trial data, and project progress, which led to significant stock price declines and legal actions. Shareholders who purchased shares around IPO dates and still hold them may seek corporate reforms, recover funds, and receive court-approved awards at no cost. The investigations highlight risks in biotech, financial services, and energy sectors tied to regulatory, safety, and financial disclosures.

Erasca Inc. trades at USD 14.12 with a market cap of $4.95 billion on Pluang as of Oct 08, 2026 20:12 WIB, showing a slight 1.26% decline in the last day. New Era Energy & Digital is priced at USD 5.55 with a market cap of $668.01 million, up 0.45% on the same date. These figures provide a snapshot of current investor sentiment towards companies involved in ongoing shareholder investigations.